Informatie:
Fout:
ID
32391
Beschrijving
Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00457574
Link
https://clinicaltrials.gov/show/NCT00457574
Trefwoorden
Versies (1)
- 29-10-18 29-10-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
29 oktober 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Solid Tumors and Lymphomas NCT00457574
Eligibility Solid Tumors and Lymphomas NCT00457574
- StudyEvent: Eligibility
Similar models
Eligibility Solid Tumors and Lymphomas NCT00457574
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Solid Neoplasm | Lymphoma
Item
patients must have a histologically or cytologically confirmed solid tumor or lymphoma
boolean
C0280100 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
C0024299 (UMLS CUI [2])
Limitation Absent Prior Therapy
Item
no limitations on allowable type and amount of prior therapy.
boolean
C0449295 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
Life Expectancy
Item
patients must have a life expectancy of greater than 8 weeks
boolean
C0023671 (UMLS CUI [1])
Organ function | Bone Marrow function
Item
patients must have normal organ and marrow function
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Blood sampling Pharmacokinetic aspects
Item
patients must be willing to submit blood sampling for planned pk analysis
boolean
C0005834 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
C0031328 (UMLS CUI [1,2])
Informed Consent
Item
patients must have the ability to understand and willingness to sign a written informed consent form
boolean
C0021430 (UMLS CUI [1])
Pharmaceutical Preparations Other Cancer treatment | Cancer treatment Other
Item
no other agents or therapies administered with the intent to treat malignancy
boolean
C0013227 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,3])
C0920425 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0205394 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,3])
C0920425 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
Exposure to GMX1777 | Exposure to GMX 1778
Item
patients with prior exposure to gmx1777 or gmx1778
boolean
C0332157 (UMLS CUI [1,1])
C2346839 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C2713488 (UMLS CUI [2,2])
C2346839 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C2713488 (UMLS CUI [2,2])
Comorbidity Uncontrolled
Item
uncontrolled, intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant women and women who are breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])